Top Story

Getty Images 2186769687 Crop
Pulmonary
FDA approves IPF drug therapy nerandomilast
It becomes the first new treatment in more than a decade for the severe lung condition.
Featured
Inhaler
COPD
COPD, asthma inhalers drive greenhouse gas emissions
Noninvasive Ventilation
COPD
Changes could boost access to noninvasive ventilation for COPD
Latest News
Pulmonary drug market forecast
Sponsored
Pulmonary drug market forecast
April 10, 2025
Getty Images 1772067238
Areteia Therapeutics reports positive phase 3 results for oral asthma drug dexpramipexole
October 6, 2025
Matthew Koslow, MD, and David Baraghoshi, PhD
AI-driven CT scan predicts lung disease outcomes at one year
October 6, 2025
Getty Images 635848020
Scientists propose ‘small lung syndrome’ category
October 3, 2025
Getty Images 979159900
Asthma
Early exposure to dog allergens may lower childhood asthma risk
Asthma
Areteia Therapeutics reports positive phase 3 results for oral asthma drug dexpramipexole
Asthma
One-two punch delivers relief for patients with severe asthma
Asthma
A 2-in-1 inhaler proves more effective than salbutamol for mild pediatric asthma
Inhaler
COPD
COPD, asthma inhalers drive greenhouse gas emissions
COPD
Changes could boost access to noninvasive ventilation for COPD
COPD
Researchers pioneer new breathing test for lung disease
COPD
Treatment helps rhinovirus infections in COPD patients
Getty Images 2186769687 Crop
Pulmonary
FDA approves IPF drug therapy nerandomilast
Pulmonary
AI-driven CT scan predicts lung disease outcomes at one year
Pulmonary
Scientists propose ‘small lung syndrome’ category
Pulmonary
Final trial data show significant benefits of sotatercept
Spotlight
Notable stories and studies
CDC respiratory virus guidance
Presented by Ascend Media
CDC respiratory virus guidance
Pulmonary drug market forecast
Presented by Ascend Media
Pulmonary drug market forecast
More from Pulmonary
One-two punch delivers relief for patients with severe asthma
The FDA updates Airsupra prescribing language based on study.
October 3, 2025
Getty Images 1321279053
A 2-in-1 inhaler proves more effective than salbutamol for mild pediatric asthma
The combination therapy of budesonide and formoterol reduces asthma attacks by almost half.
October 3, 2025
Getty Images 1346555528
Final trial data show significant benefits of sotatercept
The biologic drug helps reduce symptoms and slow progression of PH when treated early.
October 2, 2025
Getty Images 2185352631
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
Researchers pioneer new breathing test for lung disease
October 2, 2025
A volunteer undertaking a computed cardiopulmonography based breath test.
Treatment helps rhinovirus infections in COPD patients
October 2, 2025
Altesa BioSciences is hoping that its rhinovirus treatment vapendavir can disrupt the cycle of the virus in COPD patients.
A new outlook on lung scarring
Pain-detecting nerve cells also regulate inflammation and have bearing on pulmonary fibrosis.
September 25, 2025
Screenshot of computer image using advanced microscopy to look at lung immune cells causing lung fibrosis.
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
IL-10’s big role in pulmonary fibrosis
New research sheds light on the significance of the small protein in preventing lung inflammation.
September 25, 2025
UIC researchers Teruyuki Sano, PhD, (left) and Kiwook Kim, PhD, (right) have discovered that a small protein called IL-10 is critical for preventing lung inflammation and associated diseases.
Carbon dioxide may drive lung damage in COPD
Elevated levels of CO2 may play a bigger role in COPD than previously thought.
September 25, 2025
Carbon Dioxide
Benralizumab misses endpoint in COPD trial
The drug fell short of expectations in the RESOLUTE phase 3 trial.
September 25, 2025
Clinical Trial1
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Inhaled cannabis linked to higher risk of asthma, COPD
Clinicians are urged to screen patients with chronic lung disease for cannabis use and counsel them on the risks.
September 23, 2025
Getty Images 2197453361
AI-powered biomarker classifies asthmatic children at high risk for respiratory infections
Early risk identification can lead to more targeted and effective treatment plans.
September 23, 2025
Getty Images 2176692532
Pulmonary foam cells contribute to long-COVID
The unique association may help researchers better understand prevention therapies for lasting damage.
September 18, 2025
Getty Images 1086669302
Most Popular
GINA releases 2025 asthma guidelines update
Scientists propose ‘small lung syndrome’ category
AI-driven CT scan predicts lung disease outcomes at one year
The best and worst states for lung health, COPD
Overuse of common asthma inhalers linked to higher risk of death and severe attacks
Areteia Therapeutics reports positive phase 3 results for oral asthma drug dexpramipexole